BOPC.F Stock Overview
An investment trust, primarily invests in interest-bearing debt assets.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
BioPharma Credit PLC Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.87 |
| 52 Week High | US$1.25 |
| 52 Week Low | US$0.54 |
| Beta | 0.21 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | -8.34% |
| 5 Year Change | n/a |
| Change since IPO | -22.94% |
Recent News & Updates
Recent updates
Shareholder Returns
| BOPC.F | US Capital Markets | US Market | |
|---|---|---|---|
| 7D | 0% | 0.4% | -0.3% |
| 1Y | n/a | 29.9% | 22.3% |
Return vs Industry: Insufficient data to determine how BOPC.F performed against the US Capital Markets industry.
Return vs Market: Insufficient data to determine how BOPC.F performed against the US Market.
Price Volatility
| BOPC.F volatility | |
|---|---|
| BOPC.F Average Weekly Movement | n/a |
| Capital Markets Industry Average Movement | 3.5% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in US Market | 15.4% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: BOPC.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine BOPC.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2016 | n/a | n/a | www.bpcruk.com |
BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. BioPharma Credit PLC was incorporated in 2016 and is based in London, the United Kingdom.
BioPharma Credit PLC Fundamentals Summary
| BOPC.F fundamental statistics | |
|---|---|
| Market cap | US$1.03b |
| Earnings (TTM) | US$108.45m |
| Revenue (TTM) | US$135.74m |
9.5x
P/E Ratio7.6x
P/S RatioIs BOPC.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BOPC.F income statement (TTM) | |
|---|---|
| Revenue | US$135.74m |
| Cost of Revenue | US$0 |
| Gross Profit | US$135.74m |
| Other Expenses | US$27.29m |
| Earnings | US$108.45m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.089 |
| Gross Margin | 100.00% |
| Net Profit Margin | 79.90% |
| Debt/Equity Ratio | 0% |
How did BOPC.F perform over the long term?
See historical performance and comparison